Panacea Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The companys pipeline products include PAN-301-1, a human aspartyl (asparaginyl) -hydroxylase (HAAH) nanoparticle therapeutic vaccine for the treatment of prostate cancer. Panacea also develops preclinical products in serodiagnosis of cancer, monoclonal antibody-based immunotherapy of cancer, immuno-imaging of cancer, and prevention of chemotherapy-induced cognitive impairment and peripheral neuropathy. Panacea is headquartered in Gaithersburg, Maryland, the US.

Panacea Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Panacea Pharma Raises USD15 Million in Series E Financing 10
Partnerships 10
Goodwin Biotechnology Enters into Co-Development Agreement with Panacea Pharma 10
Licensing Agreements 11
Panacea Global Enters into Licensing Agreement with Panacea Pharma 11
Panacea Pharmaceuticals Inc - Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List Of Tables


Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 1
Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Panacea Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Panacea Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Panacea Pharma Raises USD15 Million in Series E Financing 10
Goodwin Biotechnology Enters into Co-Development Agreement with Panacea Pharma 10
Panacea Global Enters into Licensing Agreement with Panacea Pharma 11
Panacea Pharmaceuticals Inc, Key Competitors 13
Panacea Pharmaceuticals Inc, Key Employees 14

List Of Figures


Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23

Rocket Pharmaceuticals Inc (RCKT) - Financial and Strategic SWOT Analysis Review

Rocket Pharmaceuticals Inc (Rocket Pharma), formerly Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company. It focuses on the discovery and development of novel therapeutics for the treatment of glaucoma and

USD 300 View Report

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available